IVDR Reality Check: Are We Moving Fast Enough?

As of February 2025, around 1,500 IVDR certificates have been issued. But if an estimated 18,700 devices still need certification before the 2029 deadline, then...

Danish biotech to buy struggling American oncology company

Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.

Medicon Valley Alliance

The Covid pandemic accelerated the development of cancer vaccine

The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast ...

“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...

Här är orden som tvättas bort i Trumps USA

Den amerikanska smittskyddsmyndigheten CDC uppmanar sina forskare att dra tillbaka eller pausa alla nya forskningsstudier som är aktuella för publicering i medi...

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors used to require a relatively large amount of space or their operating time was greatly...

Thermo Fisher Scientific startar nytt labb i Göteborg

Thermo Fisher Scientific utökar sin närvaro i Europa med ett nytt bioanalytiskt laboratorium i Goco Health Innovation City i Göteborg.

Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas

Samuel Lagercrantz, Editor in Chief of Life Science Sweden, lists three medical fields in which we are currently seeing major breakthroughs and two fields in wh...

Ytterligare läkemedelskandidat mot Alzheimers droppas

Ett litet schweiziskt biotechbolag avbryter en fas II-studien med sin läkemedelskandidat mot Alzheimers sjukdom. Beskedet kommer inte långt efter att Biogen och...

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2025)

She is Sweden´s new Minister of Healthcare

Today, Tuesday, Swedish Prime Minister Ulf Kristersson, who leads the Moderate Party and the centre-right coalition in Sweden, presented the government's new mi...

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Bältrosvaccin undersöks som potentiellt skydd mot demens

Brittiska Glaxo Smith Kline undersöker om bolagets storsäljande vaccin mot bältros även minskar risken för demens.

Ancient DNA provides new insights – “The immune system lost its job”

Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...

New report: Fewer PhDs in life sciences

A new report from Vinnova suggests that competency returns in the life science sector are declining.

Utveckling av svensk KOL-behandling får stöd av amerikansk accelerator

Nystartade Mucolife Therapeutics, som utvecklar ett läkemedel mot lungsjukdomen KOL, har ingått partnerskap med ett amerikanskt acceleratorprogram.

The Swedish government is to increase its investment in cancer care

The Swedish government wants to invest more in cancer and paediatric cancer care and proposes to allocate SEK 500 million per year for this purpose in the coming years.

Trots löfte – RFK Jr. ska se över barnvaccinationer

För att släppas fram till posten som USA:s hälsominister lovade Robert F Kennedy Jr. att inte ändra de nuvarande vaccinationsprogrammen. Men nu är det just det ...

Norway rejects national life science strategy – sees no need

The Norwegian Arbeiderpartiet rejects a proposal that Norway should develop its own life science strategy.

Starkare ventilutbud med OMAL – ny leverantör hos OEM Automatic

För att möta industrins ökade krav på flexibilitet och driftsäkerhet stärker OEM Automatic sitt erbjudande inom processventiler. Genom ett nytt samarbete med de...

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

Anpassningsbara vridspjällsventiler från OMAL – lösningen för tuffa miljöer

OEM Automatic erbjuder nu vridspjällsventiler från OMAL, särskilt utvecklade för att möta höga krav inom industriella applikationer. Med hög driftsäkerhet, lång...